|
|
Line 7: |
Line 7: |
| {{SK}} CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides | | {{SK}} CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides |
|
| |
|
| ==[[Cutaneous T cell lymphoma overview|Overview]]== | | ==[[Overview]]== |
|
| |
|
| ==[[Cutaneous T cell lymphoma historical perspective|Historical Perspective]]== | | ==[[Classification]]== |
|
| |
|
| ==[[Cutaneous T cell lymphoma classification|Classification]]== | | ==[[Pathophysiology]]== |
|
| |
|
| ==[[Cutaneous T cell lymphoma pathophysiology|Pathophysiology]]== | | ==[[Causes]]== |
|
| |
|
| ==[[Cutaneous T cell lymphoma causes|Causes]]== | | ==[[Differentiating Cutaneous T cell lymphoma from other Diseases]]== |
|
| |
|
| ==[[Cutaneous T cell lymphoma differential diagnosis|Differentiating Cutaneous T cell lymphoma from other Diseases]]==
| |
|
| |
|
| ==[[Cutaneous T cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]== | | ==References== |
| | |
| ==[[Cutaneous T cell lymphoma epidemiology and demographics|Risk Factors]]==
| |
| | |
| ==[[Cutaneous T cell lymphoma screening|Screening]]==
| |
| | |
| ==[[Cutaneous T cell lymphoma natural history|Natural History, Complications and Prognosis]]==
| |
| | |
| ==Diagnosis==
| |
| [[Cutaneous T cell lymphoma staging|Staging]] | [[Cutaneous T cell lymphoma history and symptoms|History and Symptoms]] | [[Cutaneous T cell lymphoma physical examination|Physical Examination]] | [[Cutaneous T cell lymphoma laboratory tests|Laboratory Findings]] | [[Cutaneous T cell lymphoma biopsy|Biopsy]] | [[Cutaneous T cell lymphoma CT|CT]] | [[Cutaneous T cell lymphoma MRI|MRI]] | [[Cutaneous T cell lymphoma other imaging findings|Other Imaging Findings]] | [[Cutaneous T cell lymphoma other diagnostic studies|Other Diagnostic Studies]]
| |
| | |
| ==Treatment==
| |
| [[Cutaneous T cell lymphoma medical therapy|Medical Therapy]] | [[Cutaneous T cell lymphoma surgery|Surgery]] | [[Cutaneous T cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Cutaneous T cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
| |
| | |
| ==Resources==
| |
| * [http://www.lymphomainfo.net/nhl/types/ctcl-mf.html Cutaneous T-Cell Lymphomas - The lymphoma Information Network]
| |
| * [http://www.clfoundation.org/ The Cutaneous Lymphoma Foundation]
| |
| * {{DermNet|dermal-infiltrative/cutaneous-t-cell-lymphoma}}
| |
| * [http://www.lymphoma.org/ Lymphoma Research Foundation]
| |
| * [http://www.clinicaltrials.gov/ct/show/NCT00106431 NCI Clinical Trial using Depsipeptide to treat CTCL]
| |
| | |
| {{Hematological malignancy histology}}
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
|
| |
|
| [[Category:Disease]] | | [[Category:Disease]] |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Synonyms and keywords: CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides
References